Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Japan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20081
20102
20151
20182
20201
20212
20223
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bayer2
Takeda2
ARCAGY/ GINECO GROUP1
Bristol-Myers Squibb1
Daiichi Sankyo1
Gynecologic Oncology Group1
Haihe Biopharma Co., Ltd.1
Hoffmann-La Roche1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms20
Endometrial Neoplasms5
Fallopian Tube Neoplasms4
Stomach Neoplasms4
Uterine Cervical Neoplasms4
Breast Neoplasms3
Carcinoma, Ovarian Epithelial3
Colorectal Neoplasms3
Esophageal Neoplasms3
Pancreatic Neoplasms3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.